Bordetella pertussis 18323 is a rod-shaped bacterium that was isolated from unkonwn source.
rod-shaped genome sequence 16S sequence Bacteria| @ref 20215 |
|
Last LPSN update
2026-02-09 11:17:51 |
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Betaproteobacteria |
| Order Burkholderiales |
| Family Alcaligenaceae |
| Genus Bordetella |
| Species Bordetella pertussis |
| Full scientific name Bordetella pertussis (Bergey et al. 1923) Moreno-López 1952 (Approved Lists 1980) |
| Synonyms (1) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 2227 | BORDET-GENGOU-MEDIUM (DIFCO) (DSMZ Medium 438) | Medium recipe at MediaDive  | Name: BORDET-GENGOU-MEDIUM (DIFCO) (DSMZ Medium 438) Composition: Horse blood 150.0 g/l Bordet-Gengou-Agar-Base | ||
| 39796 | MEDIUM 440 - for Bordetella | Distilled water make up to (1000.000 ml);Glycerol (10.000 ml);Bordet gengou agar (30.000 g);Sheep blood (200.000 ml) | |||
| 121786 | CIP Medium 440 | Medium recipe at CIP |
| @ref | Oxygen tolerance | Confidence | |
|---|---|---|---|
| 125439 | obligate aerobe | 98 |
| @ref | Spore formation | Confidence | |
|---|---|---|---|
| 125439 | 92.8 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 22905 | 16808 ChEBI | 2-dehydro-D-gluconate | - | growth | |
| 22906 | 37054 ChEBI | 3-hydroxybutyrate | + | growth | |
| 22905 | 58143 ChEBI | 5-dehydro-D-gluconate | - | growth | |
| 22905 | 57606 ChEBI | 5-oxoproline | - | other | |
| 22906 | 30089 ChEBI | acetate | - | growth | |
| 22905 | 17128 ChEBI | adipate | - | growth | |
| 22906 | 17128 ChEBI | adipate | - | growth | |
| 22906 | 22599 ChEBI | arabinose | - | growth | |
| 22905 | 29016 ChEBI | arginine | + | other | |
| 22906 | 16947 ChEBI | citrate | + | growth | |
| 121786 | 16947 ChEBI | citrate | - | carbon source | |
| 22905 | 15356 ChEBI | cysteine | - | other | |
| 68377 | 15824 ChEBI | D-fructose | - | builds acid from | from API NH |
| 22905 | 18391 ChEBI | D-gluconate | - | growth | |
| 22905 | 17634 ChEBI | D-glucose | - | growth | |
| 22906 | 17634 ChEBI | D-glucose | + | growth | |
| 68377 | 17634 ChEBI | D-glucose | - | builds acid from | from API NH |
| 22906 | 16899 ChEBI | D-mannitol | - | growth | |
| 22906 | 16988 ChEBI | D-ribose | - | growth | |
| 22906 | 17924 ChEBI | D-sorbitol | - | growth | |
| 22905 | 65327 ChEBI | D-xylose | - | growth | |
| 22905 | 27689 ChEBI | decanoate | - | growth | |
| 22906 | 27689 ChEBI | decanoate | - | growth | |
| 22905 | 4853 ChEBI | esculin | - | growth | |
| 121786 | 4853 ChEBI | esculin | - | hydrolysis | |
| 22906 | 5291 ChEBI | gelatin | - | growth | |
| 22906 | 24265 ChEBI | gluconate | +/- | growth | |
| 22905 | 17234 ChEBI | glucose | - | fermentation | |
| 22906 | 17234 ChEBI | glucose | - | builds acid from | |
| 22905 | 5390 ChEBI | glutamyl-glutamic acid | + | other | |
| 22906 | 28087 ChEBI | glycogen | - | growth | |
| 121786 | 606565 ChEBI | hippurate | + | hydrolysis | |
| 22906 | 17240 ChEBI | itaconate | - | growth | |
| 22906 | 16977 ChEBI | L-alanine | - | growth | |
| 22906 | 30849 ChEBI | L-arabinose | - | growth | |
| 22905 | 29991 ChEBI | L-aspartate | + | other | |
| 22906 | 18287 ChEBI | L-fucose | - | growth | |
| 22906 | 15971 ChEBI | L-histidine | + | growth | |
| 22905 | 15589 ChEBI | L-malate | - | growth | |
| 22906 | 17203 ChEBI | L-proline | + | growth | |
| 22906 | 62345 ChEBI | L-rhamnose | - | growth | |
| 22906 | 17115 ChEBI | L-serine | + | growth | |
| 22906 | 24996 ChEBI | lactate | - | growth | |
| 22905 | 74534 ChEBI | leucylglycine | + | other | |
| 22906 | 25115 ChEBI | malate | + | growth | |
| 22906 | 15792 ChEBI | malonate | - | growth | |
| 121786 | 15792 ChEBI | malonate | - | assimilation | |
| 22906 | 17306 ChEBI | maltose | - | growth | |
| 68377 | 17306 ChEBI | maltose | - | builds acid from | from API NH |
| 22906 | 37684 ChEBI | mannose | - | growth | |
| 22906 | 28053 ChEBI | melibiose | - | growth | |
| 22906 | 17268 ChEBI | myo-inositol | - | growth | |
| 22906 | 506227 ChEBI | N-acetyl-D-glucosamine | - | growth | |
| 22905 | 17632 ChEBI | nitrate | - | reduction | |
| 121786 | 17632 ChEBI | nitrate | - | builds gas from | |
| 121786 | 17632 ChEBI | nitrate | - | reduction | |
| 121786 | 16301 ChEBI | nitrite | - | builds gas from | |
| 121786 | 16301 ChEBI | nitrite | + | reduction | |
| 22906 | O-nitrophenyl-beta-D-galactopyranosid | - | growth | ||
| 22905 | 18401 ChEBI | phenylacetate | - | growth | |
| 22906 | 18401 ChEBI | phenylacetate | - | growth | |
| 22905 | 28044 ChEBI | phenylalanine | + | other | |
| 22906 | 17272 ChEBI | propionate | + | growth | |
| 22906 | 17814 ChEBI | salicin | - | growth | |
| 22905 | 17822 ChEBI | serine | + | other | |
| 22906 | 76282 ChEBI | suberate | + | growth | |
| 22906 | 17992 ChEBI | sucrose | - | growth | |
| 68377 | 27897 ChEBI | tryptophan | - | energy source | from API NH |
| 22905 | 18186 ChEBI | tyrosine | + | other | |
| 68377 | 16199 ChEBI | urea | - | hydrolysis | from API NH |
| 22906 | 31011 ChEBI | valerate | + | growth | |
| 22905 | 27266 ChEBI | valine | - | other |
| @ref | Metabolite | Is sensitive | Is resistant | |
|---|---|---|---|---|
| 121786 | 0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate) |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 22906 | acid phosphatase | - | 3.1.3.2 | |
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 121786 | alcohol dehydrogenase | - | 1.1.1.1 | |
| 22906 | alkaline phosphatase | - | 3.1.3.1 | |
| 68377 | alkaline phosphatase | - | 3.1.3.1 | from API NH |
| 68382 | alkaline phosphatase | + | 3.1.3.1 | from API zym |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 22906 | alpha-galactosidase | - | 3.2.1.22 | |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 22906 | arginine dihydrolase | + | 3.5.3.6 | |
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 121786 | beta-galactosidase | - | 3.2.1.23 | |
| 68377 | beta-galactosidase | - | 3.2.1.23 | from API NH |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 68377 | beta-lactamase | - | 3.5.2.6 | from API NH |
| 121786 | caseinase | + | 3.4.21.50 | |
| 2227 | catalase | + | 1.11.1.6 | |
| 121786 | catalase | + | 1.11.1.6 | |
| 22906 | cystine arylamidase | - | 3.4.11.3 | |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 2227 | cytochrome-c oxidase | + | 1.9.3.1 | |
| 121786 | DNase | + | ||
| 68382 | esterase (C 4) | + | from API zym | |
| 22906 | esterase Lipase (C 8) | +/- | ||
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 121786 | gamma-glutamyltransferase | - | 2.3.2.2 | |
| 121786 | gelatinase | + | ||
| 121786 | lecithinase | - | ||
| 22906 | leucine arylamidase | +/- | 3.4.11.1 | |
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 121786 | lipase | - | ||
| 68377 | lipase | - | from API NH | |
| 68382 | lipase (C 14) | - | from API zym | |
| 22905 | lysine decarboxylase | - | 4.1.1.18 | |
| 121786 | lysine decarboxylase | - | 4.1.1.18 | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 22906 | naphthol-AS-BI-phosphohydrolase | +/- | ||
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 121786 | ornithine decarboxylase | - | 4.1.1.17 | |
| 121786 | oxidase | + | ||
| 121786 | phenylalanine ammonia-lyase | - | 4.3.1.24 | |
| 121786 | protease | + | ||
| 68382 | trypsin | + | 3.4.21.4 | from API zym |
| 121786 | tryptophan deaminase | - | ||
| 68377 | tryptophan deaminase | - | 4.1.99.1 | from API NH |
| 22905 | urease | - | 3.5.1.5 | |
| 121786 | urease | - | 3.5.1.5 | |
| 68377 | urease | - | 3.5.1.5 | from API NH |
| 68382 | valine arylamidase | - | from API zym |
| @ref | PEN | GLU | FRU | MAL | SAC | ODC | URE | LIP | PAL | beta GAL | ProA | GGT | IND | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2227 | - | - | - | - | - | - | - | - | - | - | - | + | - | |
| 2227 | - | - | - | - | +/- | - | - | - | - | - | + | - | - | |
| 2227 | - | - | - | - | - | - | - | - | - | - | + | - | - | |
| 2227 | - | - | - | - | - | - | - | - | - | - | + | - | - | |
| 2227 | - | - | - | - | - | - | - | - | - | - | + | - | - | |
| 2227 | - | - | - | - | - | - | - | - | - | - | + | - | - | |
| 2227 | - | - | - | - | - | - | - | - | - | - | - | + | - | |
| 2227 | - | - | - | - | - | - | - | - | - | - | - | + | - | |
| 2227 | - | - | - | - | - | - | - | - | - | - | - | + | - | |
| 2227 | - | - | - | - | - | - | - | - | - | - | - | + | - | |
| 2227 | - | - | - | - | - | - | - | - | - | - | - | + | - | |
| 2227 | - | - | - | - | - | +/- | - | - | - | - | - | + | - | |
| 2227 | - | - | - | - | - | - | - | - | - | - | - | + | - |
| 2227 | Sample typeunkonwn source |
Global distribution of 16S sequence U04950 (>99% sequence identity) for Bordetella pertussis from Microbeatlas 
 Aquatic Samples |
9586 |
 Soil Samples |
4730 |
 Animal Samples |
5464 |
 Plant Samples |
3383 |
| Total Samples | 23163 |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | Bordetella pertussis strain FDAARGOS_1543 | complete | 520.1281  | 520 | 99.35 | | ||
| 124043 | ASM2073626v1 assembly for Bordetella pertussis FDAARGOS_1543 | complete | GCA_020736265  | 520.1273 | 520 | 95.56 | | |
| 66792 | ASM30694v1 assembly for Bordetella pertussis 18323 | complete | GCA_000306945 | 568706.3 | 2912253523  | 568706 | 95.4 | |
| 66792 | ASM152555v2 assembly for Bordetella pertussis 18323 FDAARGOS_178 | contig | GCA_001525555 | 568706.6 | 2912183561 | 568706 | 43.68 | |
| 22906 | GC-content (mol%)63.8 |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Phylogeny | Detection and differentiation of Bordetella spp. by real-time PCR. | Koidl C, Bozic M, Burmeister A, Hess M, Marth E, Kessler HH. | J Clin Microbiol | 10.1128/jcm.01303-06 | 2007 | |
| Enzymology | Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. | Tsang RS, Lau AK, Sill ML, Halperin SA, Van Caeseele P, Jamieson F, Martin IE. | J Clin Microbiol | 10.1128/jcm.42.11.5364-5367.2004 | 2004 | |
| Verification and diagnostic evaluation of the RealStar® Middle East respiratory syndrome coronavirus (N gene) reverse transcription-PCR kit 1.0. | Hecht LS, Jurado-Jimenez A, Hess M, Halas HE, Bochenek G, Mohammed H, Alzahrani F, Asiri MO, Hasan R, Alamri A, Alotaibi S. | Future Microbiol | 10.2217/fmb-2019-0067 | 2019 | | |
| Enzymology | Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients. | Hogardt M, Trebesius K, Geiger AM, Hornef M, Rosenecker J, Heesemann J. | J Clin Microbiol | 10.1128/jcm.38.2.818-825.2000 | 2000 | |
| Comparative Evaluation of Recombinant and Acellular Pertussis Vaccines in a Murine Model. | Kang KR, Kim JA, Cho GW, Kang HU, Kang HM, Kang JH, Seong BL, Lee SY. | Vaccines (Basel) | 10.3390/vaccines12010108 | 2024 | | |
| Nasal immunization with compound 48/80-adjuvanted acellular pertussis vaccines is an effective strategy to induce pertussis-specific systemic and mucosal immunity. | Church AH, Abraham SN, Staats HF, Johnson-Weaver BT. | Clin Exp Vaccine Res | 10.7774/cevr.2025.14.e23 | 2025 | | |
| Genetics | Macrolide susceptibility and molecular characteristics of Bordetella pertussis. | Zhang J, Zhang D, Wang X, Wei X, Li H. | J Int Med Res | 10.1177/03000605221078782 | 2022 | |
| Clinical evaluation of a new rapid immunochromatographic test for detection of Bordetella pertussis antigen. | Okada K, Horikoshi Y, Nishimura N, Ishii S, Nogami H, Motomura C, Miyairi I, Tsumura N, Mori T, Ito K, Honma S, Nagai K, Tanaka H, Hayakawa T, Abe C, Ouchi K. | Sci Rep | 10.1038/s41598-022-11933-y | 2022 | | |
| African Trypanosomosis Obliterates DTPa Vaccine-Induced Functional Memory So That Post-Treatment Bordetella pertussis Challenge Fails to Trigger a Protective Recall Response. | Radwanska M, Nguyen HTT, Magez S. | Vaccines (Basel) | 10.3390/vaccines9060603 | 2021 | | |
| Non-primate animal models for pertussis: back to the drawing board? | Cimolai N. | Appl Microbiol Biotechnol | 10.1007/s00253-022-11798-1 | 2022 | | |
| Architecture and genomic arrangement of the MurE-MurF bacterial cell wall biosynthesis complex. | Shirakawa KT, Sala FA, Miyachiro MM, Job V, Trindade DM, Dessen A. | Proc Natl Acad Sci U S A | 10.1073/pnas.2219540120 | 2023 | | |
| Genetics | Genome diversity and evolutionary characteristics of clinical isolates of Bordetella pertussis circulating in Iran. | Saedi S, Safarchi A, Noofeli M, Tadayon K, Tay ACY, Lamichhane B, Rahimi H, Shahcheraghi F. | Iran J Microbiol | 10.18502/ijm.v12i1.2500 | 2020 | |
| Isolation of High Level Macrolide Resistant Bordetella pertussis Without Transition Mutation at Domain V in Iran. | Mirzaei B, Bameri Z, Babaei R, Shahcheraghi F. | Jundishapur J Microbiol | 10.5812/jjm.8(5)2015.18190 | 2015 | | |
| Enzymology | Multicenter Clinical Evaluation of the Automated Aries Bordetella Assay. | Relich RF, Leber A, Young S, Schutzbank T, Dunn R, Farhang J, Uphoff TS. | J Clin Microbiol | 10.1128/jcm.01471-18 | 2019 | |
| Pathogenicity | Direct Detection of Erythromycin-Resistant Bordetella pertussis in Clinical Specimens by PCR. | Wang Z, Han R, Liu Y, Du Q, Liu J, Ma C, Li H, He Q, Yan Y. | J Clin Microbiol | 10.1128/jcm.01499-15 | 2015 | |
| Commensal Microbes Affect Host Humoral Immunity to Bordetella pertussis Infection. | Zhang Y, Ran Z, Tian M, Zhou Y, Yang J, Yin J, Lu D, Li R, Zhong J. | Infect Immun | 10.1128/iai.00421-19 | 2019 | | |
| Study on Toxicity Reduction and Potency Induction in Whole-cell Pertussis Vaccine by Developing a New Optimal Inactivation Condition Processed on Bordetella pertussis. | Mohammadpour Dounighi N, Razzaghi-Abyane M, Nofeli M, Zolfagharian H, Shahcheraghi F. | Jundishapur J Microbiol | 10.5812/jjm.34153 | 2016 | | |
| Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro. | Queenan AM, Dowling DJ, Cheng WK, Fae K, Fernandez J, Flynn PJ, Joshi S, Brightman SE, Ramirez J, Serroyen J, Wiertsema S, Fortanier A, van den Dobbelsteen G, Levy O, Poolman J. | Vaccine | 10.1016/j.vaccine.2018.11.028 | 2019 | | |
| Cloning and Expression of S1 Subunit of Pertussis Toxin in Escherichia coli. | Khafri A, Aghaiypour K, Peerayeh SN, Ghorbani R. | Avicenna J Med Biotechnol | 2011 | | ||
| Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care Biochip. | Dou M, Macias N, Shen F, Bard JD, Dominguez DC, Li X. | EClinicalMedicine | 10.1016/j.eclinm.2019.02.008 | 2019 | | |
| The First Macrolide-Resistant Bordetella pertussis Strains Isolated From Iranian Patients. | Shahcheraghi F, Nakhost Lotfi M, Nikbin VS, Shooraj F, Azizian R, Parzadeh M, Allahyar Torkaman MR, Zahraei SM. | Jundishapur J Microbiol | 10.5812/jjm.10880 | 2014 | | |
| Evaluation of amplification targets for the specific detection of Bordetella pertussis using real-time polymerase chain reaction. | Hasan MR, Tan R, Al-Rawahi GN, Thomas E, Tilley P. | Can J Infect Dis Med Microbiol | 10.1155/2014/763128 | 2014 | | |
| Metabolism | The MurG glycosyltransferase provides an oligomeric scaffold for the cytoplasmic steps of peptidoglycan biosynthesis in the human pathogen Bordetella pertussis. | Laddomada F, Miyachiro MM, Jessop M, Patin D, Job V, Mengin-Lecreulx D, Le Roy A, Ebel C, Breyton C, Gutsche I, Dessen A. | Sci Rep | 10.1038/s41598-019-40966-z | 2019 | |
| Metabolism | Recent trends of antigenic variation in Bordetella pertussis isolates in Korea. | Kim SH, Lee J, Sung HY, Yu JY, Kim SH, Park MS, Jung SO. | J Korean Med Sci | 10.3346/jkms.2014.29.3.328 | 2014 | |
| Enzymology | Use of Bordetella pertussis BP3385 to establish a cutoff value for an IS481-targeted real-time PCR assay. | Guthrie JL, Seah C, Brown S, Tang P, Jamieson F, Drews SJ. | J Clin Microbiol | 10.1128/jcm.01551-08 | 2008 | |
| Enzymology | Evaluation of specificity of BP3385 for Bordetella pertussis detection. | Register KB, Nicholson TL, Guthrie JL. | J Clin Microbiol | 10.1128/jcm.00945-10 | 2010 | |
| Evaluation of real-time PCR for diagnosis of Bordetella pertussis infection. | Knorr L, Fox JD, Tilley PA, Ahmed-Bentley J. | BMC Infect Dis | 10.1186/1471-2334-6-62 | 2006 | | |
| Development and evaluation of a loop-mediated isothermal amplification method for rapid diagnosis of Bordetella pertussis infection. | Kamachi K, Toyoizumi-Ajisaka H, Toda K, Soeung SC, Sarath S, Nareth Y, Horiuchi Y, Kojima K, Takahashi M, Arakawa Y. | J Clin Microbiol | 10.1128/jcm.44.5.1899-1902.2006 | 2006 | | |
| Factors Associated With MALDI-TOF Mass Spectral Quality of Species Identification in Clinical Routine Diagnostics. | Cuenod A, Foucault F, Pfluger V, Egli A. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.646648 | 2021 | | |
| Phylogeny | Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance. | Wilson KE, Cassiday PK, Popovic T, Sanden GN. | J Clin Microbiol | 10.1128/jcm.40.8.2942-2944.2002 | 2002 | |
| Genetics | Multilocus Sequence Analysis of Housekeeping Genes and Antigenic Determinant Genes in Bordetella pertussis Strains Isolated in Korea. | Jung SO, Moon YM, Kim SH, Sung HY, Kwon SJ, Kang YH, Yu JY. | Osong Public Health Res Perspect | 10.1016/j.phrp.2011.08.003 | 2011 | |
| Pathogenicity | In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). | Hoppe JE, Bryskier A. | Antimicrob Agents Chemother | 10.1128/aac.42.4.965 | 1998 | |
| Phylogeny | Multiplex LightCycler PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis in nasopharyngeal specimens. | Sloan LM, Hopkins MK, Mitchell PS, Vetter EA, Rosenblatt JE, Harmsen WS, Cockerill FR, Patel R. | J Clin Microbiol | 10.1128/jcm.40.1.96-100.2002 | 2002 | |
| Polymorphism in the pertussis toxin promoter region affecting the DNA-based diagnosis of Bordetella infection. | Nygren M, Reizenstein E, Ronaghi M, Lundeberg J. | J Clin Microbiol | 10.1128/jcm.38.1.55-60.2000 | 2000 | | |
| Enzymology | Evaluation of real-time PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis. | Templeton KE, Scheltinga SA, van der Zee A, Diederen BM, van Kruijssen A, Goossens H, Kuijper E, Claas EC. | J Clin Microbiol | 10.1128/jcm.41.9.4121-4126.2003 | 2003 | |
| A new modified animal model of myosin-induced experimental autoimmune myositis enhanced by defibrase. | Wen-Jing L, Chuan-Qiang P, Hong-Hua L, Xiang-Hui L, Jie-Xiao L. | Arch Med Sci | 10.5114/aoms.2015.52883 | 2015 | | |
| Pathogenicity | A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents. | Hill BC, Baker CN, Tenover FC. | J Clin Microbiol | 10.1128/jcm.38.3.1151-1155.2000 | 2000 | |
| A rapid, specific, extraction-less, and cost-effective RT-LAMP test for the detection of SARS-CoV-2 in clinical specimens. | Marino FE, Proffitt E, Joseph E, Manoharan A. | PLoS One | 10.1371/journal.pone.0266703 | 2022 | | |
| Enzymology | Impact of nasopharyngeal swab types on detection of Bordetella pertussis by PCR and culture. | Cloud JL, Hymas W, Carroll KC. | J Clin Microbiol | 10.1128/jcm.40.10.3838-3840.2002 | 2002 | |
| Phylogeny | Fluorescence in situ hybridization for rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis recovered from cystic fibrosis patients. | Wellinghausen N, Wirths B, Poppert S. | J Clin Microbiol | 10.1128/jcm.00508-06 | 2006 | |
| Metabolism | Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract. | Carbonetti NH, Artamonova GV, Van Rooijen N, Ayala VI. | Infect Immun | 10.1128/iai.01578-06 | 2007 | |
| Simultaneous Detection of Nine Key Bacterial Respiratory Pathogens Using Luminex xTAG® Technology. | Jiang L, Ren H, Zhou H, Qin T, Chen Y. | Int J Environ Res Public Health | 10.3390/ijerph14030223 | 2017 | | |
| Enzymology | Regulation of inflammatory responses to Bordetella pertussis by N(G)-monomethyl-L-arginine in mice intranasally infected. | Torre D, Speranza F, Pugliese A, Fassina G, Osculati A, Perversi L, Banfi MG, Airoldi M. | Mediators Inflamm | 10.1080/09629359990685 | 1999 | |
| Rapid PCR Detection of Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum. | Cunningham SA, Mandrekar JN, Rosenblatt JE, Patel R. | Int J Bacteriol | 10.1155/2013/168742 | 2013 | | |
| Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein. | Carbonetti NH, Artamonova GV, Andreasen C, Dudley E, Mays RM, Worthington ZE. | Infect Immun | 10.1128/iai.72.6.3350-3358.2004 | 2004 | | |
| Pathogenicity | In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones. | Hoppe JE, Simon CG. | Antimicrob Agents Chemother | 10.1128/aac.34.11.2287 | 1990 | |
| Enzymology | Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis. | Hallander HO, Reizenstein E, Renemar B, Rasmuson G, Mardin L, Olin P. | J Clin Microbiol | 10.1128/jcm.31.1.50-52.1993 | 1993 | |
| T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice. | Ausiello CM, Lande R, Stefanelli P, Fazio C, Fedele G, Palazzo R, Urbani F, Mastrantonio P. | Clin Diagn Lab Immunol | 10.1128/cdli.10.4.637-642.2003 | 2003 | | |
| Pertussis toxin plays an early role in respiratory tract colonization by Bordetella pertussis. | Carbonetti NH, Artamonova GV, Mays RM, Worthington ZE. | Infect Immun | 10.1128/iai.71.11.6358-6366.2003 | 2003 | | |
| Pathogenicity | In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to six new oral cephalosporins. | Hoppe JE, Muller J. | Antimicrob Agents Chemother | 10.1128/aac.34.7.1442 | 1990 | |
| Enzymology | Nested PCR optimized for detection of Bordetella pertussis in clinical nasopharyngeal samples. | Backman A, Johansson B, Olcen P. | J Clin Microbiol | 10.1128/jcm.32.10.2544-2548.1994 | 1994 | |
| Viability of Bordetella pertussis in four suspending solutions at three temperatures. | Cassiday PK, Sanden GN, Kane CT, M'Boup S, Barbaree JM. | J Clin Microbiol | 10.1128/jcm.32.6.1550-1553.1994 | 1994 | | |
| Neither the Bvg- phase nor the vrg6 locus of Bordetella pertussis is required for respiratory infection in mice. | Martinez de Tejada G, Cotter PA, Heininger U, Camilli A, Akerley BJ, Mekalanos JJ, Miller JF. | Infect Immun | 10.1128/iai.66.6.2762-2768.1998 | 1998 | | |
| Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytes. | Hazenbos WL, van den Berg BM, van't Wout JW, Mooi FR, van Furth R. | Infect Immun | 10.1128/iai.62.11.4818-4824.1994 | 1994 | | |
| Contribution of regulation by the bvg locus to respiratory infection of mice by Bordetella pertussis. | Merkel TJ, Stibitz S, Keith JM, Leef M, Shahin R. | Infect Immun | 10.1128/iai.66.9.4367-4373.1998 | 1998 | | |
| Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France. | Grimprel E, Begue P, Anjak I, Njamkepo E, Francois P, Guiso N. | Clin Diagn Lab Immunol | 10.1128/cdli.3.1.93-97.1996 | 1996 | | |
| Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates. | Mastrantonio P, Stefanelli P, Giuliano M, Herrera Rojas Y, Ciofi degli Atti M, Anemona A, Tozzi AE. | J Clin Microbiol | 10.1128/jcm.36.4.999-1002.1998 | 1998 | | |
| Quantitative priming with inactivated pertussis toxoid vaccine in the aerosol challenge model. | Bruss JB, Siber GR. | Infect Immun | 10.1128/iai.70.8.4600-4608.2002 | 2002 | | |
| Comparison of bipA alleles within and across Bordetella species. | Fuchslocher B, Millar LL, Cotter PA. | Infect Immun | 10.1128/iai.71.6.3043-3052.2003 | 2003 | | |
| Enzymology | Immunomagnetic separation and solid-phase detection of Bordetella pertussis. | Stark M, Reizenstein E, Uhlen M, Lundeberg J. | J Clin Microbiol | 10.1128/jcm.34.4.778-784.1996 | 1996 | |
| Production of recombinant Bordetella pertussis serotype 2 fimbriae in Bordetella parapertussis and Bordetella bronchiseptica: utility of Escherichia coli gene expression signals. | Walker MJ, Guzman CA, Rohde M, Timmis KN. | Infect Immun | 10.1128/iai.59.5.1739-1746.1991 | 1991 | | |
| Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines. | Ausiello CM, Lande R, Urbani F, la Sala A, Stefanelli P, Salmaso S, Mastrantonio P, Cassone A. | Infect Immun | 10.1128/iai.67.8.4064-4071.1999 | 1999 | | |
| Differences in coughing and other responses to intrabronchial infection with Bordetella pertussis among strains of rats. | Hall E, Parton R, Wardlaw AC. | Infect Immun | 10.1128/iai.65.11.4711-4717.1997 | 1997 | | |
| Enzymology | Validation of nested Bordetella PCR in pertussis vaccine trial. | Reizenstein E, Lindberg L, Mollby R, Hallander HO. | J Clin Microbiol | 10.1128/jcm.34.4.810-815.1996 | 1996 | |
| Metabolism | Detection and subcellular localization of three Ptl proteins involved in the secretion of pertussis toxin from Bordetella pertussis. | Johnson FD, Burns DL. | J Bacteriol | 10.1128/jb.176.17.5350-5356.1994 | 1994 | |
| Enzymology | Characterization of vir-activated TnphoA gene fusions in Bordetella pertussis. | Finn TM, Shahin R, Mekalanos JJ. | Infect Immun | 10.1128/iai.59.9.3273-3279.1991 | 1991 | |
| Repressor binding to a regulatory site in the DNA coding sequence is sufficient to confer transcriptional regulation of the vir-repressed genes (vrg genes) in Bordetella pertussis. | Beattie DT, Mahan MJ, Mekalanos JJ. | J Bacteriol | 10.1128/jb.175.2.519-527.1993 | 1993 | | |
| Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis. | Martin D, Peppler MS, Brodeur BR. | Infect Immun | 10.1128/iai.60.7.2718-2725.1992 | 1992 | | |
| Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge model. | Bruss JB, Siber GR. | Clin Diagn Lab Immunol | 10.1128/cdli.6.4.464-470.1999 | 1999 | | |
| Enzymology | Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs. | Stefanelli P, Mastrantonio P, Hausman SZ, Giuliano M, Burns DL. | J Clin Microbiol | 10.1128/jcm.35.6.1550-1555.1997 | 1997 | |
| A new assay for invasion of HeLa 229 cells by Bordetella pertussis: effects of inhibitors, phenotypic modulation, and genetic alterations. | Lee CK, Roberts AL, Finn TM, Knapp S, Mekalanos JJ. | Infect Immun | 10.1128/iai.58.8.2516-2522.1990 | 1990 | | |
| Genetics | Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. | Heininger U, Cotter PA, Fescemyer HW, Martinez de Tejada G, Yuk MH, Miller JF, Harvill ET. | Infect Immun | 10.1128/iai.70.7.3777-3784.2002 | 2002 | |
| Enzymology | Development of a rapid PCR assay specific for Staphylococcus saprophyticus and application to direct detection from urine samples. | Martineau F, Picard FJ, Menard C, Roy PH, Ouellette M, Bergeron MG. | J Clin Microbiol | 10.1128/jcm.38.9.3280-3284.2000 | 2000 | |
| Expression of pertussis toxin in Bordetella bronchiseptica and Bordetella parapertussis carrying recombinant plasmids. | Lee CK, Roberts A, Perrin S. | Infect Immun | 10.1128/iai.57.5.1413-1418.1989 | 1989 | | |
| Phylogeny | Development of a PCR assay for identification of staphylococci at genus and species levels. | Martineau F, Picard FJ, Ke D, Paradis S, Roy PH, Ouellette M, Bergeron MG. | J Clin Microbiol | 10.1128/jcm.39.7.2541-2547.2001 | 2001 | |
| Enzymology | Use of tuf sequences for genus-specific PCR detection and phylogenetic analysis of 28 streptococcal species. | Picard FJ, Ke D, Boudreau DK, Boissinot M, Huletsky A, Richard D, Ouellette M, Roy PH, Bergeron MG. | J Clin Microbiol | 10.1128/jcm.42.8.3686-3695.2004 | 2004 | |
| Purification and subunit heterogeneity of pili of Bordetella bronchiseptica. | Lee SW, Way AW, Osen EG. | Infect Immun | 10.1128/iai.51.2.586-593.1986 | 1986 | | |
| Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. | Arico B, Rappuoli R. | J Bacteriol | 10.1128/jb.169.6.2847-2853.1987 | 1987 | | |
| Development of a PCR assay for rapid detection of enterococci. | Ke D, Picard FJ, Martineau F, Menard C, Roy PH, Ouellette M, Bergeron MG. | J Clin Microbiol | 10.1128/jcm.37.11.3497-3503.1999 | 1999 | | |
| Pathogenicity | New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. | Huletsky A, Giroux R, Rossbach V, Gagnon M, Vaillancourt M, Bernier M, Gagnon F, Truchon K, Bastien M, Picard FJ, van Belkum A, Ouellette M, Roy PH, Bergeron MG. | J Clin Microbiol | 10.1128/jcm.42.5.1875-1884.2004 | 2004 | |
| Rapid identification of mycobacteria and drug-resistant Mycobacterium tuberculosis by use of a single multiplex PCR and DNA sequencing. | Perez-Osorio AC, Boyle DS, Ingham ZK, Ostash A, Gautom RK, Colombel C, Houze Y, Leader BT. | J Clin Microbiol | 10.1128/jcm.05570-11 | 2012 | | |
| Metabolism | Real-time fluorogenic reverse transcription-PCR assays for detection of bacteriophage MS2. | O'Connell KP, Bucher JR, Anderson PE, Cao CJ, Khan AS, Gostomski MV, Valdes JJ. | Appl Environ Microbiol | 10.1128/aem.72.1.478-483.2006 | 2006 | |
| Enzymology | Detection of Mycobacterium tuberculosis by PCR amplification with pan-Mycobacterium primers and hybridization to an M. tuberculosis-specific probe. | Tevere VJ, Hewitt PL, Dare A, Hocknell P, Keen A, Spadoro JP, Young KK. | J Clin Microbiol | 10.1128/jcm.34.4.918-923.1996 | 1996 | |
| Phylogeny | Phylogenetic analysis of Ara+ and Ara- Burkholderia pseudomallei isolates and development of a multiplex PCR procedure for rapid discrimination between the two biotypes. | Dharakul T, Tassaneetrithep B, Trakulsomboon S, Songsivilai S. | J Clin Microbiol | 10.1128/jcm.37.6.1906-1912.1999 | 1999 | |
| Epicillin: in vitro laboratory studies. | Basch H, Erickson R, Gadebusch H. | Infect Immun | 10.1128/iai.4.1.44-49.1971 | 1971 | | |
| Shared antigens between heterologous bacterial species. | Minden P, McClatchy JK, Farr RS. | Infect Immun | 10.1128/iai.6.4.574-582.1972 | 1972 | | |
| Analysis of a repetitive DNA sequence from Bordetella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction. | Glare EM, Paton JC, Premier RR, Lawrence AJ, Nisbet IT. | J Clin Microbiol | 10.1128/jcm.28.9.1982-1987.1990 | 1990 | | |
| Comparative Assessment of the Whole-cell Pertussis Vaccine Potency Using Serological and Intracerebral Mouse Protection Methods. | Mohammadbagher D, Noofeli M, Karimi G | Arch Razi Inst | 10.22092/ari.2018.108852.1096 | 2019 | | |
| Enzymology | Genetic analysis of clinical and vaccine strains of Bordetella pertussis by Pulsed-Field Gel Electrophoresis (PFGE), Multi Locus Sequence Typing (MLST) and serotyping. | Bahmanjeh A, Noofeli M, Khaki P, Hassanzadeh SM | Comp Immunol Microbiol Infect Dis | 10.1016/j.cimid.2019.03.010 | 2019 | |
| Pathogenicity | [Immunobiological properties of Bordetella pertussis lipopolysaccharide in the acellular pertussis vaccine]. | Zaitsev EM, Poddubikov AV, Britsina MV, Mertsalova NU, Ozeretskovskaia MN, Bazhanova IG, Plekhanova NG | Zh Mikrobiol Epidemiol Immunobiol | 2014 | | |
| Pathogenicity | [Preclinical studies of an adsorbed diphtheria-tetanus-pertussis vaccine (ADTP-vaccine) with acellular pertussis component]. | Zaitsev EM, Britsina MV, Bazhanova IG, Mertsalova NU, Ozeretskovskaia MN, Ermolova EV, Plekhanova NG, Mikhailova NA, Kolyshkin VA, Zverev VV | Zh Mikrobiol Epidemiol Immunobiol | 2013 | | |
| Metabolism | The RNA chaperone Hfq is required for virulence of Bordetella pertussis. | Bibova I, Skopova K, Masin J, Cerny O, Hot D, Sebo P, Vecerek B | Infect Immun | 10.1128/IAI.00345-13 | 2013 | |
| Pathogenicity | The Bordetella pertussis type III secretion system tip complex protein Bsp22 is not a protective antigen and fails to elicit serum antibody responses during infection of humans and mice. | Villarino Romero R, Bibova I, Cerny O, Vecerek B, Wald T, Benada O, Zavadilova J, Osicka R, Sebo P | Infect Immun | 10.1128/IAI.00353-13 | 2013 | |
| Pathogenicity | Bactericidal activity of topical antiseptics and their gargles against Bordetella pertussis. | Suzuki T, Kataoka H, Ida T, Kamachi K, Mikuniya T | J Infect Chemother | 10.1007/s10156-011-0312-4 | 2011 | |
| Metabolism | A natural pertactin deficient strain of Bordetella pertussis shows improved entry in human monocyte-derived dendritic cells. | Stefanelli P, Fazio C, Fedele G, Spensieri F, Ausiello CM, Mastrantonio P | New Microbiol | 2009 | | |
| Evaluation of two serological methods for potency testing of whole cell pertussis vaccines. | von Hunolstein C, Gomez Miguel MJ, Pezzella C, Scopetti F, Behr-Gross ME, Halder M, Hoffmann S, Levels L, van der Gun J, Hendriksen C | Pharmeuropa Bio | 2008 | | ||
| Pathogenicity | Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. | Packard ER, Parton R, Coote JG, Fry NK | J Med Microbiol | 10.1099/jmm.0.05515-0 | 2004 | |
| Pathogenicity | Mitochondrial alterations precede Bordetella pertussis-induced apoptosis. | Bachelet M, Richard MJ, Francois D, Polla BS | FEMS Immunol Med Microbiol | 10.1111/j.1574-695X.2002.tb00544.x | 2002 | |
| Genetics | Mass spectrometric analysis of recombinant adenylate cyclase toxin from Bordetella pertussis strain 18323/pHSP9. | Havlicek V, Higgins L, Chen W, Halada P, Sebo P, Sakamoto H, Hackett M | J Mass Spectrom | 10.1002/jms.139 | 2001 | |
| The Pertussis Serological Potency Test. Collaborative study to evaluatereplacement of the Mouse Protection Test. | van der Ark A, van Straaten-van de Kappelle I, Olander RM, Enssle K, Jadhav S, van de Donk H, Hendriksen C | Biologicals | 10.1006/biol.2000.0247 | 2000 | | |
| Genetics | Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine. | Boursaux-Eude C, Thiberge S, Carletti G, Guiso N | Vaccine | 10.1016/s0264-410x(99)00038-9 | 1999 | |
| Metabolism | Vag8, a Bordetella pertussis bvg-regulated protein. | Finn TM, Amsbaugh DF | Infect Immun | 10.1128/IAI.66.8.3985-3989.1998 | 1998 | |
| Enzymology | Tracheal colonization factor: a Bordetella pertussis secreted virulence determinant. | Finn TM, Stevens LA | Mol Microbiol | 10.1111/j.1365-2958.1995.tb02425.x | 1995 | |
| Enzymology | Identification of a Bordetella pertussis bvg-regulated porin-like protein. | Finn TM, Li Z, Kocsis E | J Bacteriol | 10.1128/jb.177.3.805-809.1995 | 1995 | |
| Metabolism | Bordetella pertussis extract induces increase in the activities of glycolytic enzymes in mouse liver. | Shyamala S, Sengupta SR, Ramakrishnan P | Indian J Biochem Biophys | 1992 | | |
| Pertussis whole cell vaccine: relation between intracerebral protection in mice and antibody response to pertussis toxin, filamentous hemagglutinin and adenylate cyclase. | Dellepiane NI, Manghi MA, Eriksson PV, di Paola G, Cangelosi A | Zentralbl Bakteriol | 10.1016/s0934-8840(11)80872-8 | 1992 | | |
| Enzymology | A vir-repressed gene of Bordetella pertussis is required for virulence. | Beattie DT, Shahin R, Mekalanos JJ | Infect Immun | 10.1128/iai.60.2.571-577.1992 | 1992 | |
| Enzymology | [Structural organization of a segment of chromosome, containing the vir gene of Bordetella pertussis]. | Karataev GI, Shumakov IuL, Kirillov MIu, Volgina TI, Lapaeva IA | Mol Gen Mikrobiol Virusol | 1990 | | |
| Metabolism | Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen. | Kimura A, Mountzouros KT, Schad PA, Cieplak W, Cowell JL | Infect Immun | 10.1128/iai.58.10.3337-3347.1990 | 1990 | |
| Genetics | Construction and characterization in vivo of Bordetella pertussis aroA mutants. | Roberts M, Maskell D, Novotny P, Dougan G | Infect Immun | 10.1128/iai.58.3.732-739.1990 | 1990 | |
| Enzymology | Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. | Shahin RD, Brennan MJ, Li ZM, Meade BD, Manclark CR | J Exp Med | 10.1084/jem.171.1.63 | 1990 | |
| Genetics | Evolutionary relationships in the genus Bordetella. | Arico B, Gross R, Smida J, Rappuoli R | Mol Microbiol | 10.1111/j.1365-2958.1987.tb01936.x | 1987 | |
| Antigenic heterogeneity in subunit S1 of pertussis toxin. | Perera VY, Wardlaw AC, Freer JH | J Gen Microbiol | 10.1099/00221287-132-2-553 | 1986 | | |
| Enzymology | Bordetella adenylate cyclase: a genus specific protective antigen and virulence factor. | Novotny P, Chubb AP, Cownley K, Montaraz JA, Beesley JE | Dev Biol Stand | 1985 | | |
| Phylogeny | Studies on phase variation in Bordetella pertussis. | Goldman S, Hanski E, Fish F | Dev Biol Stand | 1985 | | |
| Enzymology | Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen. | Zhang JM, Cowell JL, Steven AC, Manclark CR | Dev Biol Stand | 1985 | | |
| Phenotype | Spontaneous phase variation in Bordetella pertussis is a multistep non-random process. | Goldman S, Hanski E, Fish F | EMBO J | 10.1002/j.1460-2075.1984.tb01976.x | 1984 | |
| Transplacental and transcolostral immunity to pertussis in a mouse model using acellular pertussis vaccine. | Oda M, Izumiya K, Sato Y, Hirayama M | J Infect Dis | 10.1093/infdis/148.1.138 | 1983 | | |
| Enzymology | [Isolation and purification of a preparation possessing leukocytosis-stimulating properties from pertussis bacteria]. | Trofimova NP, Demina AA, Igonina IuA, Dolomanova MS, Syresina GI | Zh Mikrobiol Epidemiol Immunobiol | 1977 | | |
| Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with Bordetella pertussis: Study of the Case of the Pertussis Vaccine Used in the Expanded Vaccination Program in Algeria. | Tahar Djebbar K, Allouache M, Kezzal S, Benguerguoura F, TouilBoukoffa C, Zidi I, Raache R, Ouzari HI | Vaccines (Basel) | 10.3390/vaccines10060906 | 2022 | | |
| Phylogeny | Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia. | Weyant RS, Hollis DG, Weaver RE, Amin MF, Steigerwalt AG, O'Connor SP, Whitney AM, Daneshvar MI, Moss CW, Brenner DJ. | J Clin Microbiol | 10.1128/jcm.33.1.1-7.1995 | 1995 | |
| Phylogeny | Parapusillimonas granuli gen. nov., sp. nov., isolated from granules from a wastewater-treatment bioreactor. | Kim YJ, Kim MK, Im WT, Srinivasan S, Yang DC | Int J Syst Evol Microbiol | 10.1099/ijs.0.009720-0 | 2009 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive374.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License